EndoChoice Holdings, Inc. 4

4 · EndoChoice Holdings, Inc. · Filed Nov 23, 2016

Form 4

Period: 2016-11-22

Director

Transactions

Disposition to Issuer
Common stock, par value $0.001 per share
2016-11-22$8.00/sh−21,235$169,880→ 0 total
Disposition to Issuer
Employee Stock Option (right to buy)
2016-11-22−20,736→ 0 total
Exercise: $2.83Exp: 2019-12-16→ Common stock, par value $0.001 per share (20,736 underlying)
Disposition to Issuer
Employee Stock Option (right to buy)
2016-11-22−4,156→ 0 total
Exercise: $3.32Exp: 2022-01-24→ Common stock, par value $0.001 per share (4,156 underlying)

Footnotes (3)

[F1]Reporting Person disposed of shares of Issuer Common Stock pursuant to a cash tender offer made by Boston Scientific Corporation as more fully described in the Schedule 14D-9 filed by Issuer with the Securities and Exchange Commission on October 7, 2016, and subsequent amendments thereto (the "Merger"). The Issuer's Board of Directors approved in advance the dispositions by the Reporting Person in the tender offer.
[F2]Issuer's outstanding stock options, if not yet vested, became fully vested pursuant to the terms and conditions of the Merger.
[F3]This option was cancelled pursuant to the Merger in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $8.00 per share.

Documents

1 file